| Generic Name | Azithromycin for Injection USP |
|---|---|
| Brand Reference | Zithromax® |
| DIN | 02483890 |
| GTIN | 834324002644 |
| Strength | 500 mg |
| Format | Vial |
| Pack Size | 10 |
| Therapeutic Class | Antibiotic |
| Product Insert | Click Here |
| Product Monograph | Click Here |
| SteriMax | ST-DM112 |
|---|---|
| McKesson: | 139771 |
| McMahon: | 10109093 |
| K&F: | 130971 |
| Jean Coutu: | 757276 |
| Unipharm: | 02407351 |
Latex Free Stopper
Preservative Free
| Provincial Formulary Coverage | ✓:Listed | P:Pending | I:Interchangeable Only |
|---|
| BC | AB | SK | MB | ON | QC | NB | PE | NS | NL |
|---|---|---|---|---|---|---|---|---|---|
| N/A | N/A | N/A | N/A | N/A | ✓ | N/A | N/A | N/A | N/A |
Azithromycin for Injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
1. Community-acquired pneumonia (CAP) due to Chlamydia pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Legionella pneumophila, Mycoplasma pneumoniae or Streptococcus pneumoniae in patients who require initial intravenous therapy.
2. Pelvic inflammatory disease (PID) due to Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma hominis in patients who require initial intravenous therapy.
English
